Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH; REVEAL-HBV Study Group.

JAMA. 2006 Jan 4;295(1):65-73.

PMID:
16391218
2.

Natural history of chronic hepatitis B REVEALed.

Chen CJ, Yang HI.

J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. Review.

PMID:
21323729
3.

What can we learn from hepatitis B virus clinical cohorts?

Lin CL, Tseng TC, Kao JH.

Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716. Review.

PMID:
25529093
4.

Natural history of chronic hepatitis B: what exactly has REVEAL revealed?

Iloeje UH, Yang HI, Chen CJ.

Liver Int. 2012 Oct;32(9):1333-41. doi: 10.1111/j.1478-3231.2012.02805.x. Epub 2012 Apr 17. Review.

PMID:
22510145
5.

Perspectives and control of hepatitis B virus infection in Taiwan.

Lin CL, Kao JH.

J Formos Med Assoc. 2015 Oct;114(10):901-9. doi: 10.1016/j.jfma.2015.06.003. Epub 2015 Jul 13. Review.

6.

The prognosis and management of inactive HBV carriers.

Invernizzi F, ViganĂ² M, Grossi G, Lampertico P.

Liver Int. 2016 Jan;36 Suppl 1:100-4. doi: 10.1111/liv.13006. Review.

PMID:
26725905
7.

Chronic hepatitis B virus infection in Asian countries.

Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.

J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. Review.

PMID:
11197043
8.

Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.

Lin CL, Kao JH.

J Biomed Sci. 2008 Mar;15(2):137-45. Epub 2007 Dec 5. Review.

PMID:
18058038
9.

HBV: Do I treat my immunotolerant patients?

Vlachogiannakos J, Papatheodoridis GV.

Liver Int. 2016 Jan;36 Suppl 1:93-9. doi: 10.1111/liv.12996. Review.

PMID:
26725904
10.
11.

Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis.

Raffetti E, Fattovich G, Donato F.

Liver Int. 2016 Sep;36(9):1239-51. doi: 10.1111/liv.13142. Epub 2016 May 22. Review.

PMID:
27062182
12.

Epidemiology of viral hepatitis and hepatocellular carcinoma.

El-Serag HB.

Gastroenterology. 2012 May;142(6):1264-1273.e1. doi: 10.1053/j.gastro.2011.12.061. Review.

13.

Significance of viral status on occurrence of hepatitis B-related hepatocellular carcinoma.

Qu LS, Zhou GX.

World J Gastroenterol. 2014 May 28;20(20):5999-6005. doi: 10.3748/wjg.v20.i20.5999. Review.

14.

Association between metabolic factors and chronic hepatitis B virus infection.

Chiang CH, Huang KC.

World J Gastroenterol. 2014 Jun 21;20(23):7213-6. doi: 10.3748/wjg.v20.i23.7213. Review.

15.

Viral hepatitis and liver cancer in Korea: an epidemiological perspective.

Yeo Y, Gwack J, Kang S, Koo B, Jung SJ, Dhamala P, Ko KP, Lim YK, Yoo KY.

Asian Pac J Cancer Prev. 2013;14(11):6227-31. Review.

16.

Epidemiology and natural history of hepatitis C virus infection.

Lee MH, Yang HI, Yuan Y, L'Italien G, Chen CJ.

World J Gastroenterol. 2014 Jul 28;20(28):9270-80. doi: 10.3748/wjg.v20.i28.9270. Review.

17.

Hepatitis B and hepatocellular carcinoma.

Di Bisceglie AM.

Hepatology. 2009 May;49(5 Suppl):S56-60. doi: 10.1002/hep.22962.

18.

Hepatitis B virus epidemiology.

MacLachlan JH, Cowie BC.

Cold Spring Harb Perspect Med. 2015 May 1;5(5):a021410. doi: 10.1101/cshperspect.a021410. Review.

19.

Natural history of chronic hepatitis B: phases in a complex relationship.

Croagh CM, Lubel JS.

World J Gastroenterol. 2014 Aug 14;20(30):10395-404. doi: 10.3748/wjg.v20.i30.10395. Review.

20.

Analysis of Risk Factors Associated with the Development of Hepatocellular Carcinoma in Chronic HBV-Infected Chinese: A Meta-Analysis.

Lyu X, Liu K, Chen Y, Wang Z, Yao J, Cai G, Jiang Z, Wang Z, Jiang J, Gu H.

Int J Environ Res Public Health. 2016 Jun 17;13(6). pii: E604. doi: 10.3390/ijerph13060604. Review.

Supplemental Content

Support Center